Digital Pharmacist

DECEMBER 15, 2022

CVS MinuteClinics provide lab testing, clinical services, COVID-19 testing, and vaccination with or without an appointment. However, vaccination is the most frequently conducted service in community pharmacies, therefore, every community pharmacy should possess vaccines in stock and prepare their pharmacists not to miss sales opportunities.

Community Pharmacies 98

Community Pharmacies Independent Pharmacies Vaccines Communication 98

IDStewardship

MAY 12, 2023

BCPS, BCIDP Article posted: 12 May 2023 The ASHP pharmacy residency match phases 1 and 2 have come to a close. For example in infectious diseases we have things like tropical medicine, travel vaccines, microbiology breakpoints, immunocompromised hosts, infection prevention, and regulatory requirements. Authored by: Timothy P.

Communication 130

Communication Documentation Vaccines 130

STAT

FEBRUARY 1, 2024

The need-to-know this morning Merck   reported  earnings for the fourth-quarter and 2023. In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. In the end, Novavax will have reduced its workforce by about 30% compared to 2023, part of an effort to reduce its expenses in the months to come.

Vaccines 120

Vaccines Communication Insurance 120

Pharmafile

DECEMBER 9, 2022

Pfizer has announced that the FDA has accepted its application for a respiratory syncytial virus (RSV) vaccine for older adults, with the FDA expected to come to a decision by Spring 2023. The FDA will review the application under the priority review programme, meaning the approval timeline should be reduced by four months.

Vaccines 59

Vaccines FDA Communication 59

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

European Pharmaceutical Review

JANUARY 31, 2023

A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs).

Communication 105

Communication Vaccines 105

The Happy PharmD

SEPTEMBER 15, 2024

Well, now’s the perfect time to dive into a discussion with me about the latest insights from the 2023 report by the Well-Being Index. Watch this discussion on YouTube: 2023 Well-Being Report: Are Pharmacist Stress Levels Being Downplayed? The post State of Well-Being 2023-2024 appeared first on The Happy PharmD.

Documentation 52

Documentation Dosage Communication Insurance 52

Prescribe Wellness

DECEMBER 9, 2022

For the best results, patients should consider getting vaccinated by the end of October, as it takes 2 weeks for a body to build up full flu protection. Can I get the flu shot and the COVID-19 vaccine at the same time? Patients with severe, life-threatening allergies to any ingredient in a flu vaccine should not get a flu shot.

Vaccines 75

Vaccines Communication Immunization 75

European Pharmaceutical Review

JULY 21, 2023

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. How can these issues be addressed?

Vaccines 98

Vaccines FDA Communication Hospitals 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Vaccines Communication Labelling 97

PQA

APRIL 5, 2023

PQA’s February 16, 2023, Quality Forum welcomed Andrew Thorne, PharmD, MS, Senior Manager, Data Analytics at Pharmacy Quality Solutions (PQS), to provide data insights into the PQS Industry Trend Report in Pharmacy Quality for 2022. One surprising trend was whether respondents had received a vaccination at the pharmacy.

Vaccines 52

Vaccines Community Pharmacies Specialty Pharmacies Independent Pharmacies 52

PQA

MAY 8, 2024

As pharmacies evolve and embrace digital communications, patient preferences are evolving, too. More than 95% of patients are comfortable receiving communications about prescriptions from pharmacists, including information about vaccines, according to Outcomes’ 2023 consumer survey. 1. Identify barriers to adherence.

Communication 45

Communication Vaccines 45

The Checkup by Singlecare

SEPTEMBER 27, 2023

Nitrofurantoin can interact with certain antacids, gout medications, anesthetics, and travel vaccines. This includes some antacids, gout medications, anesthetics, and travel vaccines, as well as methotrexate and fluconazole. This includes the oral typhoid and cholera vaccines. They might prescribe an alternative treatment.

Vaccines 52

Vaccines Mayo Clinic Compounding Communication 52

Pharma Marketing Network

DECEMBER 17, 2021

This is likely something we will be living with until we crack the code on how to vaccinate the unvaccinated, and even then we’re all likely to be getting boosters for a long-time. Increasingly pharma is embracing AI to facilitate next-best-actions and next-best-engagements with respect to it’s omnichannel marketing communications.

Customer Service 105

Customer Service Vaccines Communication 105

ISPE

OCTOBER 26, 2022

It seems like yesterday, and now the 2022 ISPE Annual Meeting & Expo in Orlando, Florida, has come and gone, and Mike Rutherford is the 2022–2023 Chair. This interaction was used to further improve the ISPE Charter, and the proposed changes will be implemented into the 2023 version. One ISPE and Strategic Plan Refresh.

Packaging 52

Packaging Compounding Communication Vaccines 52

The Checkup by Singlecare

OCTOBER 6, 2023

Other methylprednisolone interactions In those receiving high doses of corticosteroids, generally defined as systemic (as opposed to topical or inhaled) doses equivalent to more than 2 mg/kg or 20 mg/day of prednisone for more than two weeks, live vaccines should not be administered.

Vaccines 52

Vaccines Mayo Clinic FDA Immunization 52

The Checkup by Singlecare

NOVEMBER 13, 2023

To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. It is a two-vaccine series and significantly decreases the risk of a shingles outbreak. Asthma is a non-communicable disease that causes difficulty in breathing, and it may cause sharp pain on the right side of the chest.

Mayo Clinic 52

Mayo Clinic Vaccines Chemotherapy Communication 52

ISPE

MARCH 8, 2023

Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S. In the Moderna COVID-19 vaccine contamination case, three lots of the five lots affected, totaling 1.63 How Did 75M J&J Vaccines Get Ruined?

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

The FDA Law Blog

AUGUST 21, 2023

Further, FDA has utilized a variety of strategies to call attention to safety issues through Dear Doctor letters or other forms of communication, even if directing changes to labeling is difficult. Liability is precisely why the vaccine market shrunk so significantly in the 1980s, going from 26 manufacturers to 4, after lawsuits claiming $3.5

Labelling 40

Labelling FDA Vaccines Communication 40

Pharmaceutical Technology

JANUARY 20, 2023

In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. billion in Covid-19 vaccine sales.

Vaccines 98

Vaccines Communication FDA 98

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. Those available commercially include adenoviral-based vaccines by AstraZeneca and Johnson & Johnson. References. Globaldata.com.

Vaccines 115

Vaccines Documentation Communication Hospitals 115

ISPE

MAY 9, 2023

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Trudy Patterson Tue, 05/09/2023 - 09:34 Features May / June 2023 Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Scott Fotheringham, PhD 1 May 2023 North Carolina’s Research Triangle is the largest of its kind in the US.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

ISPE

AUGUST 7, 2023

She noted the speed with which the industry developed vaccines and treatments as well as how regulatory agencies adapted to carrying out inspections remotely using digital technologies while maintaining GMP and GCP standards even as the necessary resources came under great pressure. Clearly, we could not do it alone,” she said.

Vaccines 52

Vaccines Communication 52

ISPE

MARCH 1, 2023

Biopharmaceutical active ingredients, such as anti-cancer drugs, insulin, vaccines and infusions are produced in these highly complex, "tailor-made" facilities. You may unsubscribe from these ISPE communications at any time. ZETA acts as a one-stop shop, combining plant engineering with HVAC and cleanroom design.

Communication 52

Communication Vaccines 52

ISPE

FEBRUARY 1, 2023

Biopharmaceutical active ingredients, such as anti-cancer drugs, insulin, vaccines and infusions are produced in these highly complex, "tailor-made" facilities. You may unsubscribe from these ISPE communications at any time. ZETA acts as a one-stop shop, combining plant engineering with HVAC and cleanroom design.

Communication 52

Communication Vaccines 52

ISPE

JANUARY 3, 2023

Tue, 01/03/2023 - 07:38. 1 January 2023. Biopharmaceutical active ingredients, such as anti-cancer drugs, insulin, vaccines and infusions are produced in these highly complex, "tailor-made" facilities. You may unsubscribe from these ISPE communications at any time. Seamless Integration with Any Automation Environment.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 52

Hospital Pharmacy Europe

JULY 27, 2023

This represents an important step in the prevention of HIV, especially given the failure of a HIV vaccine earlier in 2023. After the second initiation injection, the recommended continuation injection dose is a single 600 mg (3 ml) injection every two months.

Communication 52

Communication Immunization Vaccines Hospitals 52

ISPE

SEPTEMBER 11, 2023

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. 7 June 2023. Nature Communications 12, no. McQueen Nina S. link] 2 Lee, K.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

PharmaShots

APRIL 3, 2023

Shots: The first quarter of 2023 highlights major acquisitions in the pharma and biotech industry along with multiple approvals. Date - Jan 04, 2023 Product – N/A The acquisition is completed from a shareholder group led by Nordic Capital, in an all-cash transaction valued at $2.8B per ADS up front & CVR of ~$2.50

FDA 40

FDA Compounding Vaccines Hospitals 40

ISPE

AUGUST 16, 2023

He pointed out that the most recently developed MRAs were established between the EMA and the FDA and include inspections for veterinary products, vaccines, and plasma-derived products. The pilot, aimed at evaluating the impact of reliance on PIC/s authorities for GMP verification, began in October 2022 and will be completed in December 2023.

Communication 52

Communication FDA Vaccines 52

ISPE

JUNE 27, 2023

Korakianiti also referred to first QIG Workshop held in early March 2023 at which case studies in continuous and decentralized manufacturing were presented and discussed. Processes are in place to check on the impact on MRAs with the need to communicate with partners and evaluate at national level.

Communication 52

Communication FDA Vaccines 52

ISPE

JANUARY 10, 2023

Rapid Filter or Resin Change Strategies for Biomanufacturing Trudy Patterson Tue, 01/10/2023 - 14:05 Technical January / February 2023 Rapid Filter or Resin Change Strategies for Biomanufacturing Amy C. You may unsubscribe from these ISPE communications at any time. Dowd, PhD Rob Deitcher Brian Kelley Nina S.

Packaging 52

Packaging FDA Communication Vaccines 52

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines 52

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 22, 2023

The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. Pfizer/BioNTech then countersued in December 2022. CureVac is seeking fair compensation for Comirnaty revenue.

Vaccines 116

Vaccines Communication 116

Pharmaceutical Technology

MAY 4, 2023

After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD).

Vaccines 64

Vaccines FDA Communication Immunization 64

Pharmaceutical Technology

MARCH 21, 2023

Source: GlobalData Pharmaceutical Intelligence Center Clinical trial catalysts In late January, AC Immune released positive interim results from the Phase I/II trial (NCT05462106) studying the company’s vaccine in patients with prodromal Alzheimer’s disease. Please check your email to download the Report.

Packaging 59

Packaging FDA Vaccines Communication 59

Pharmaceutical Technology

MARCH 20, 2023

The mRNA technology that enabled the largest and fastest vaccine rollout in history is the tip of the innovation iceberg. Poolberg Pharma is deploying AI algorithms on early-stage clinical data to prioritise and reposition vaccine candidates for respiratory syncytial virus. Please check your email to download the Report.

Vaccines 90

Vaccines Communication Hospitals 90